Please be advised that Good Days will be closed on Friday, March 29th, 2024 in observance of Good Friday. We will resume normal hours of operation Monday, April 1st at 8:00 AM Central Standard Time. 

 
Diseases Covered

Metastatic Castrate Resistant Prostate Cancer

All pictures shown are used for illustrative purposes only.

Program Status

closed

Applications or renewals for this condition are currently unavailable. The organizations below may offer funding for this condition.

Copay Assistance Organizations

These sister charities are also dedicated to helping people afford life-changing treatments and medications.

Support Organizations

These organizations do not offer co-pay assistance, but they offer valuable information and support.

Eligibility Criteria
  • Patient must be diagnosed with a covered disease and program must be accepting enrollments
  • Patient must have a valid Social Security number to apply for assistance and receive treatment in the United States
  • Patient must be seeking assistance for a prescribed medication that is FDA approved to treat the covered diagnosis
  • Patient is required to have valid Medicare or Military insurance coverage
  • Patient income level must be at or below 500% of the Federal Poverty Level (FPL)
  • Abiraterone
  • Asmalpred
  • Docefrez
  • Docetaxel
  • Firmagon
  • Jevtana
  • Keytruda
  • Medicort
  • Millipred
  • Orapred
  • Orapred ODT
  • Pediapred
  • Prednisolone
  • Provenge
  • Taxotere
  • Vitrakvi
  • Xofigo
  • Xtandi
  • Yonsa
  • Zytiga

Prostate cancer that keeps growing even when the amount of testosterone in the body is reduced to very low levels. Many early-stage prostate cancers need normal levels of testosterone to grow, but castrate-resistant prostate cancers do not. (Source: NIH; National Cancer Institute)

Eligibility Criteria

  • Patient must be diagnosed with a covered disease and program must be accepting enrollments
  • Patient must have a valid Social Security number to apply for assistance and receive treatment in the United States
  • Patient must be seeking assistance for a prescribed medication that is FDA approved to treat the covered diagnosis
  • Patient is required to have valid Medicare or Military insurance coverage
  • Patient income level must be at or below 500% of the Federal Poverty Level (FPL)

Medications Covered

  • Abiraterone
  • Asmalpred
  • Docefrez
  • Docetaxel
  • Firmagon
  • Jevtana
  • Keytruda
  • Medicort
  • Millipred
  • Orapred
  • Orapred ODT
  • Pediapred
  • Prednisolone
  • Provenge
  • Taxotere
  • Vitrakvi
  • Xofigo
  • Xtandi
  • Yonsa
  • Zytiga

Disease Description

Prostate cancer that keeps growing even when the amount of testosterone in the body is reduced to very low levels. Many early-stage prostate cancers need normal levels of testosterone to grow, but castrate-resistant prostate cancers do not. (Source: NIH; National Cancer Institute)

Frequently Asked Questions

Your questions answered.

Visit Our Blog

Find medical news, health and fitness tips, and patient stories.